LAKELAND INDUSTRIES INC LAKE

Healthcare SIC 3842 - Orthopedic, Prosthetic & Surgical Appliances & Supplies NAICS Manufacturing › Miscellaneous Manufacturing › Medical Equipment and Supplies Manufacturing › Surgical Appliance and Supplies Manufacturing derived Nasdaq

Overview – Lakeland Fire + Safety is a global provider of quality safety products that protect the world's workers, first responders, and communities during the most critical situations. The Company's products, which are governed by rigorous safety standards and regulations, are used to either protect the wearer from their environment or protect a product or process from the wearer in a broad range of markets around the world, including chemical, clean room, energy, fire service, manufacturing, and utility applications. Lakeland's product portfolio includes firefighter protective apparel and accessories, high-end chemical protective suits, limited use/disposable protective clothing, durable woven garments, high performance FR/AR apparel, and high visibility clothing. On March 27, 2026, the Company sold its high performance FR/AR apparel and high visibility clothing line to National Safety Apparel. For additional information, please see Note 14 to our consolidated financial statements.

Last close 9.59 2026-10-23
Market cap $94.6M 2026-04-30 share count
52-week range 7.15 - 17.72

Valuation FY2026 figures against the last close

P/S—
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS—

Annual financial statements

Income statement

Fiscal year FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue —$192.6M$167.2M$124.7M$112.8M$118.4M$159.0M$107.8M$99.0M$96.0M
Cost of revenue —$129.3M$98.5M$73.5M$67.0M$67.5M$79.7M$69.9M$65.1M$59.8M
Gross profit —$63.3M$68.7M$51.2M$45.8M$50.9M$79.3M$37.9M$33.9M$36.2M
R&D ——————$200.0K$200.0K$200.0K$280.0K
Total operating expenses —$77.0M$67.4M$45.2M$40.3M$34.9M$35.4M$32.0M$30.3M$27.7M
Operating income —-$15.5M-$9.3M$6.0M$5.5M$16.0M$43.9M$5.9M$3.6M$8.5M
Interest expense —$2.1M$1.6M$52.0K$37.0K$15.0K$23.0K$116.0K$125.0K$163.0K
Pre-tax income —-$17.7M-$18.4M$9.4M$5.5M$16.2M$43.9M$5.8M$3.5M$8.3M
Income tax —$7.6M$281.0K$3.9M$3.6M$4.8M$8.6M$2.5M$2.0M$7.9M
Net income —-$25.3M-$18.1M$5.4M$1.9M$11.4M$35.3M$3.3M$1.5M$440.0K
EPS, basic —-2.63-2.430.740.251.444.430.410.180.06
EPS, diluted —-2.63-2.430.720.241.414.340.410.180.06
Shares, diluted (wtd. avg.) —9.6M7.4M7.5M7.7M8.1M8.1M8.0M8.2M7.7M

Balance sheet

Fiscal year FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents —$12.5M$17.5M$25.2M$24.6M$52.7M$52.6M$14.6M$12.8M$15.8M
Short-term investments ———$2.2M$0—————
Receivables —$32.0M$27.6M$19.2M$17.3M$14.8M$21.7M$17.7M$16.5M$14.1M
Inventory —$82.5M$82.7M$51.2M$58.2M$47.7M$43.6M$44.2M$42.4M$42.9M
Total current assets —$134.2M$136.5M$101.5M$105.6M$120.6M$123.3M$79.8M$75.5M$76.5M
Property, plant and equipment —$11.6M$13.9M$10.7M$9.1M$8.7M$9.8M$10.1M$10.8M$8.8M
Goodwill —$15.3M$16.2M$13.7M$8.5M$871.0K$871.0K$871.0K$871.0K$871.0K
Other intangibles —$31.7M$25.5M$6.8M$6.0M$0————
Total assets —$209.9M$212.5M$153.7M$142.9M$140.8M$139.6M$99.4M$94.7M$94.5M
Accounts payable —$15.6M$15.7M$7.4M$6.6M$5.9M$7.4M$7.2M$6.2M$6.9M
Short-term debt —$1.9M$939.0K$298.0K$405.0K$0$0$1.2M$158.0K$158.0K
Total current liabilities —$38.0M$34.9M$18.3M$18.6M$12.0M$16.2M$12.9M$10.3M$10.4M
Long-term debt —$30.4M$16.4M————$0$1.2M$1.3M
Total liabilities —$80.8M$65.9M$30.3M$22.9M$15.7M$17.8M$14.4M$11.5M$11.7M
Retained earnings —$23.9M$50.3M$69.3M$64.8M$62.9M$51.5M$17.6M$14.3M$12.8M
Total equity —$129.1M$146.6M$123.5M$120.0M$125.1M$121.8M$85.1M$83.2M$82.8M

Cash flow

Fiscal year FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Operating cash flow —-$15.8M-$15.9M$10.9M-$5.5M$12.8M$40.7M$3.6M$1.8M$648.0K
Depreciation and amortisation —$2.8M$2.6M$1.9M$1.5M$1.9M$2.0M$1.6M$965.0K$775.0K
Stock-based compensation —$3.4M$1.6M$1.4M$1.5M$1.7M$1.7M-$403.0K$744.0K$424.0K
Capital expenditure —$671.0K$1.5M$2.1M$2.0M$801.0K$1.7M$1.0M$3.1M$905.0K
Investing cash flow —-$1.2M-$47.7M-$5.1M-$14.8M-$3.6M-$1.7M-$1.0M-$3.1M-$905.0K
Financing cash flow —$12.5M$56.6M-$3.5M-$5.9M-$9.8M-$1.3M-$688.0K-$1.6M$5.6M
Dividends paid —$1.2M$887.0K$908.0K——————

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001193125-26-167279.

Plot the figures US dollars

  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -100M 0 100M 200M Revenue, FY2017: 96M Gross profit, FY2017: 36.2M Net income, FY2017: 440K Revenue, FY2018: 99M Gross profit, FY2018: 33.9M Net income, FY2018: 1.5M Revenue, FY2019: 107.8M Gross profit, FY2019: 37.9M Net income, FY2019: 3.3M Revenue, FY2020: 159M Gross profit, FY2020: 79.3M Net income, FY2020: 35.3M Revenue, FY2021: 118.4M Gross profit, FY2021: 50.9M Net income, FY2021: 11.4M Revenue, FY2022: 112.8M Gross profit, FY2022: 45.8M Net income, FY2022: 1.9M Revenue, FY2023: 124.7M Gross profit, FY2023: 51.2M Net income, FY2023: 5.4M Revenue, FY2024: 167.2M Gross profit, FY2024: 68.7M Net income, FY2024: -18.1M Revenue, FY2025: 192.6M Gross profit, FY2025: 63.3M Net income, FY2025: -25.3M FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025 FY2026
Fiscal year FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue $96.0M $99.0M $107.8M $159.0M $118.4M $112.8M $124.7M $167.2M $192.6M —
Gross profit $36.2M $33.9M $37.9M $79.3M $50.9M $45.8M $51.2M $68.7M $63.3M —
Net income $440.0K $1.5M $3.3M $35.3M $11.4M $1.9M $5.4M -$18.1M -$25.3M —

Recent filings and events

  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Results announced Item 2.02
  • Regulation FD disclosure Item 7.01
  • Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
  • Regulation FD disclosure Item 7.01
  • Officer or director change Item 5.02
  • Regulation FD disclosure Item 7.01
  • Officer or director change Item 5.02

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 3842

TickerCompanyMarket capP/ERevenue growth
ISRG INTUITIVE SURGICAL INC $159.78B 57.5x 20.5%
EW Edwards Lifesciences Corp $51.34B 48.7x 11.5%
STE STERIS plc $22.63B 29.3x 8.7%
ZBH ZIMMER BIOMET HOLDINGS, INC. $18.80B 27.8x 7.2%
ALGN ALIGN TECHNOLOGY INC $10.98B 27.3x 0.9%
MSA MSA Safety Inc $7.03B 25.7x 3.7%
ESTA ESTABLISHMENT LABS HOLDINGS INC. $1.90B — 27.1%
CDRE Cadre Holdings, Inc. $1.28B 29.4x 7.5%